Renal Cancer - Results from #2620

An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours. July 30, 2020

PET imaging in urology: a rapidly growing successful collaboration. July 30, 2020

Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis. July 29, 2020

Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence? July 29, 2020

Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma. July 29, 2020

Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments. July 28, 2020

Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma. July 28, 2020

Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms. July 28, 2020

Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. July 28, 2020

Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma. July 27, 2020

Decreased mitochondrial DNA content drives OXPHOS dysregulation in chromophobe renal cell carcinoma. July 27, 2020

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma. July 27, 2020

Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma. July 24, 2020

Anomalous retro-psoas iliac artery in a patient with right renal cancer: A case report. July 24, 2020

Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma. July 23, 2020

Management of Residual or Recurrent Disease Following Thermal Ablation of Renal Cortical Tumors. July 23, 2020

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis. July 23, 2020

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial. July 23, 2020

Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience. July 22, 2020

Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases. July 22, 2020

Page 132 of 456